| Mrs Brooke Leigh Oftedal, MS, CCC-SLP | |
|
1750 Morocco Dr, Billings, MT 59105-5430 | |
| (406) 671-1854 | |
| Not Available |
| Full Name | Mrs Brooke Leigh Oftedal |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1750 Morocco Dr, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003383092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-SP-LIC-7301 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brooke Leigh Oftedal, MS, CCC-SLP 1750 Morocco Dr, Billings, MT 59105-5430 Ph: (406) 671-1854 | Mrs Brooke Leigh Oftedal, MS, CCC-SLP 1750 Morocco Dr, Billings, MT 59105-5430 Ph: (406) 671-1854 |
News Archive
A new report from the American Society of Plastic Surgeons (ASPS) reveals that Americans spent more than ever before - $16 billion - on cosmetic plastic surgery and minimally-invasive procedures in 2016.
House GOP leaders have scheduled for Jan. 12 a much-awaited and politically charged vote to repeal the health law. In the background, news organizations report on the positions being taken by Democrats who may have voted against the measure the first time around and how Republicans plan to explain the budget implications of this repeal effort.
Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to generate and evaluate in preclinical studies LAIV candidates against influenza A(H7N9).
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
› Verified 3 days ago
Jessica Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1597 Avenue D Ste 4, Billings, MT 59102 Phone: 406-690-6996 | |
Kathryn Marie Satterfield, MCSDCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3940 Rimrock Rd, Billings, MT 59102 Phone: 406-655-5658 Fax: 406-655-5639 | |
Emily Berendts Anderson, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Latisha Lee Montgomery, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-7166 | |
Rock Creek Teletherapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1302 24th St W, Suite 132, Billings, MT 59102 Phone: 888-241-4332 Fax: 406-794-0454 | |
Kelly Marie Geary Ruggles, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 Broadwater Ave, Billings, MT 59101 Phone: 406-259-1680 Fax: 406-259-1777 |